North Star Playbook
Back securities whose issuer mission aligns with investor outcomes
- Difficulty
- Moderate
- Time to result
- ~weeks to results
- Steps
- 5
- Confidence
- 86%
The North Star Playbook evaluates a company and its securities by connecting mission, execution ability, and investor alignment. The analyst first identifies whether the issuer has clear objectives rather than a vague collection of ambitions. Next comes an execution test: management must possess the resources, incentives, and operational capacity to deliver those objectives. The chosen bond or other instrument is then examined for alignment. A strong company can still issue a security whose structure transfers too much risk to investors, while a less celebrated issuer may offer a well-protected instrument aligned with its plan. The final decision reflects both sides of the relationship—whether the company can reach its North Star and whether reaching it produces the expected outcome for the security holder.
Origin
Extracted from Masters in Business
Core principles
- 01A clear corporate mission makes execution easier to evaluate
- 02Issuer objectives must align with the chosen instrument
- 03Operational capability matters alongside strategic intent
- 04Misalignment can turn a promising company into a poor security
- 05Judge the security through the issuer's ability to execute
How to run it
- 1
Identify the North Star
State the company's mission and the specific objectives management is pursuing. Require clarity about what successful execution would look like.
Pro tip Use management actions and capital allocation to verify stated objectives.
Watch out Marketing language alone does not establish a genuine North Star.
- 2
Test Execution Capacity
Assess whether the issuer has the leadership, assets, financing, and operational capability to achieve its objectives.
Pro tip Look for repeated evidence that management can deliver against milestones.
Watch out A compelling objective cannot compensate for weak execution.
- 3
Inspect the Instrument
Analyze the bond or security's structure, protections, maturity, and position in the capital stack.
Pro tip Evaluate the exact instrument rather than relying on the company's overall reputation.
Watch out Company success does not automatically produce security-holder success.
- 4
Check Alignment
Determine whether management's desired actions improve or threaten the investor's outcome. Identify incentives that could cause value to shift elsewhere.
Pro tip Model what management rationally does when conditions deteriorate.
Watch out Misaligned incentives often become most damaging during stress.
- 5
Classify and Size
Classify the company-instrument pair as aligned, misaligned, or execution-impaired, then size or avoid it accordingly.
Pro tip Demand a larger margin of safety when alignment is incomplete.
Watch out Do not let a strong narrative justify an oversized position.
In the wild
A company has a clear objective to complete contracted infrastructure, capable operators, and long-term customers. Its bond covenants preserve project cash flows for debt service, so successful execution benefits both management and creditors. The investor classifies the bond as aligned and sizes it according to construction and tenant risks.
→ The security provides a traceable path from company execution to creditor return.
A fast-growing issuer can execute its expansion plan, but its bond permits additional senior borrowing and aggressive asset transfers. Management's success may accrue primarily to equity while weakening existing creditors. The playbook rejects the bond despite confidence in the business.
→ The investor avoids confusing company quality with instrument quality.
Common mistakes
Underwriting the Brand
A respected issuer can offer an instrument whose protections and incentives are unfavorable to creditors.
Ignoring Execution Ability
Clear objectives create no value when management lacks the ability or resources to deliver them.
Assuming Shared Incentives
Management, equity holders, and bondholders may benefit from very different actions, especially under stress.
Is it for you?
Best for
It is best for evaluating corporate bonds and companies where management actions materially determine credit outcomes.
Not ideal for
It is not ideal for purely macro instruments whose outcomes are largely independent of issuer execution.
From the transcript
“We have something called the north Star Playbook”
“what are companies and bonds that have clear missions and objectives that they can execute on, that are aligned with us with the instrument that…”
From the episode
Risk and Reward with Marek Capital Co-Founder Matt Cherwin